BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 9754081)

  • 21. Metastatic breast lobular carcinoma involving tamoxifen-associated endometrial polyps: report of two cases and review of tamoxifen-associated polypoid uterine lesions.
    Houghton JP; Ioffe OB; Silverberg SG; McGrady B; McCluggage WG
    Mod Pathol; 2003 Apr; 16(4):395-8. PubMed ID: 12692205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial.
    Boccardo F; Rubagotti A; Puntoni M; Guglielmini P; Amoroso D; Fini A; Paladini G; Mesiti M; Romeo D; Rinaldini M; Scali S; Porpiglia M; Benedetto C; Restuccia N; Buzzi F; Franchi R; Massidda B; Distante V; Amadori D; Sismondi P
    J Clin Oncol; 2005 Aug; 23(22):5138-47. PubMed ID: 16009955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Monitoring of postmenopausal women treated with tamoxifen for breast carcinoma].
    Epifani S; Lattarulo S; Maiorino R; Fabiano G
    G Chir; 2000; 21(6-7):310-2. PubMed ID: 10916956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative study of the endometrial pathology using flexible ambulatory hysteroscopy of patients treated with Tamoxifen].
    Kuzmanov B
    Akush Ginekol (Sofiia); 2004; 43(3):32-3. PubMed ID: 15341254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian cysts in tamoxifen-treated women with breast cancer.
    Inal MM; Incebiyik A; Sanci M; Yildirim Y; Polat M; Pilanci B; Nayki C; Camuzcuoğlu H
    Eur J Obstet Gynecol Reprod Biol; 2005 May; 120(1):104-6. PubMed ID: 15866095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A clinicopathologic study on patients with endometrial cancer after adjuvant tamoxifen treatment for breast cancer: a single center experience.
    Ravazoula P; Androutsopoulos G; Zyli P; Michail G; Kardamakis DM; Kourounis G
    Breast J; 2006; 12(6):578-84. PubMed ID: 17238994
    [No Abstract]   [Full Text] [Related]  

  • 27. A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women.
    Chan SS; Tam WH; Yeo W; Yu MM; Ng DP; Wong AW; Kwan WH; Yuen PM
    BJOG; 2007 Dec; 114(12):1510-5. PubMed ID: 17995495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
    Swerdlow AJ; Jones ME;
    J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic changes in endometrial polyps associated with tamoxifen show no evidence for its action as an external carcinogen.
    Dal Cin P; Timmerman D; Van den Berghe I; Wanschura S; Kazmierczak B; Vergote I; Deprest J; Neven P; Moerman P; Bullerdiek J; Van den Berghe H
    Cancer Res; 1998 Jun; 58(11):2278-81. PubMed ID: 9622058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors of endometrial polyps resected from postmenopausal patients with breast carcinoma treated with tamoxifen.
    Cohen I; Azaria R; Bernheim J; Shapira J; Beyth Y
    Cancer; 2001 Sep; 92(5):1151-5. PubMed ID: 11571728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indication for histological examination of endometrium in breast carcinoma patients receiving tamoxifen therapy.
    Ito T; Katagiri C; Murata Y; Hamazoe R; Morita K
    J Obstet Gynaecol Res; 2001 Jun; 27(3):141-5. PubMed ID: 11561830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gynecologic surveillance of women on tamoxifen.
    Schwartz PE
    Conn Med; 1994 Sep; 58(9):515-21. PubMed ID: 7956197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Errors in the measurement of endometrial depth using transvaginal sonography in postmenopausal women on tamoxifen: random error is reduced using saline instillation sonography.
    Ballard P; Tetlow R; Richmond I; Killick S; Purdie DW
    Ultrasound Obstet Gynecol; 2000 Apr; 15(4):321-6. PubMed ID: 10895453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of correlation between risk factors for endometrial cancer and the presence of tamoxifen-associated endometrial polyps in postmenopausal patients with breast cancer.
    Timmerman D; Deprest J; Verbesselt R; Moerman P; De Brabanter J; Vergote I
    Eur J Cancer; 2000 Sep; 36 Suppl 4():S40-2. PubMed ID: 11056312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clear cell adenocarcinoma within a tamoxifen-related polyp.
    Yamazawa K; Matsui H; Ishikura H; Seki K; Sekiya S
    Acta Obstet Gynecol Scand; 2002 Oct; 81(10):985-7. PubMed ID: 12366493
    [No Abstract]   [Full Text] [Related]  

  • 36. Endometrial polyp with sex cord-like pattern.
    De Quintal MM; De Angelo Andrade LA
    Int J Gynecol Pathol; 2006 Apr; 25(2):170-2. PubMed ID: 16633067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of endometrial adenocarcinoma in two asymptomatic postmenopausal women receiving tamoxifen. A report of two cases.
    Look K; Sanders B; Eastlund M; Sutton G
    J Reprod Med; 1999 Nov; 44(11):977-80. PubMed ID: 10589411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lobular carcinoma metastasis to endometrial polyp unrelated to tamoxifen. Report of a case and review of the literature.
    Manipadam MT; Walter NM; Selvamani B
    APMIS; 2008 Jun; 116(6):538-40. PubMed ID: 18754330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endometrial intraepithelial neoplasia.
    Wheeler DT
    Adv Anat Pathol; 2004 Jul; 11(4):221. PubMed ID: 15220825
    [No Abstract]   [Full Text] [Related]  

  • 40. Tamoxifen-induced endometrial carcinoma after a lag of 14 years.
    Dhull AK; Kaushal V; Singh S; Sen R
    South Asian J Cancer; 2013 Jan; 2(1):6. PubMed ID: 24455532
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.